Circulating microRNAs as promising diagnostic biomarkers for hepatocellular carcinoma: a systematic review and meta-analysis

E Alemayehu, A Fasil, H Ebrahim, Z Mulatie… - Frontiers in Molecular …, 2024 - frontiersin.org
Introduction: Hepatocellular carcinoma (HCC), the most common type of liver cancer, is a
major global health problem, ranking as the third leading cause of cancer-related death …

[HTML][HTML] Non-Coding RNAs as Potential Diagnostic/Prognostic Markers for Hepatocellular Carcinoma

F Tonon, C Grassi, D Tierno, A Biasin, M Grassi… - International Journal of …, 2024 - mdpi.com
The increasing incidence of hepatocellular carcinoma (HCC), together with the poor
effectiveness of the available treatments, make early diagnosis and effective screening of …

[HTML][HTML] N7-methylguanosine-related miRNAs predict hepatocellular carcinoma prognosis and immune therapy

L Ma, Q Ma, Q Deng, J Zhou, Y Zhou, Q Wei… - Aging (Albany …, 2023 - ncbi.nlm.nih.gov
Abstract N7-methylguanosine (m 7 G) modification has been notably linked with the
development of many tumors. However, no investigations have been conducted on whether …

The anti-cancer properties of miR-340 plasmid-chitosan complexes (miR-340 CC) on murine model of breast cancer

S Kashefi, S Mohammadi-Yeganeh… - Journal of Drug …, 2024 - Taylor & Francis
ABSTRACT MiRNA-340 (miR-340) has been found to have tumor-suppressing effects in
breast cancer (BC). However, for clinical use, miRNAs need to be delivered safely and …

MicroRNAs as Plasma Biomarkers of Hepatocellular Carcinoma in Patients with Liver Cirrhosis—A Cross-Sectional Study

R Zenlander, H Salter, S Gilg, G Eggertsen… - International Journal of …, 2024 - mdpi.com
Ultrasound screening for hepatocellular carcinoma (HCC) in patients with liver cirrhosis has
a poor sensitivity for small tumors. Circulating microRNAs (miRNAs) have been explored as …

Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study

K Sartorius, B Sartorius, C Winkler… - International Journal of …, 2024 - mdpi.com
The incidence and mortality of hepatocellular carcinoma (HCC) in Sub-Saharan Africa is
projected to increase sharply by 2040 against a backdrop of limited diagnostic and …

[HTML][HTML] What are the changes in the hotspots and frontiers of microRNAs in hepatocellular carcinoma over the past decade?

L Zhang, ZY Chen, XX Wei, JD Li… - World Journal of Clinical …, 2024 - ncbi.nlm.nih.gov
BACKGROUND Emerging research suggests that microRNAs (miRNAs) play an important
role in the development of hepatocellular carcinoma (HCC). A comprehensive analysis of …

A liquid biopsy assay for the noninvasive detection of lymph node metastases in T1 lung adenocarcinoma

X Li, Y Gu, B Hu, MM Shao, H Li - Thoracic Cancer, 2024 - Wiley Online Library
Introduction Lung adenocarcinoma (LUAD) is a common pathological type of lung cancer.
The presence of lymph node metastasis plays a crucial role in determining the overall …

Predictive role of pretreatment circulating miR-221 in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

N Pinjaroen, P Chailapakul, S Sriphoosanaphan… - Diagnostics, 2023 - mdpi.com
Aberrantly expressed circulating microRNAs (miRNAs) have been demonstrated to have a
crucial role in the diagnosis and prognostication of various cancers, including hepatocellular …

The roles and mechanisms of miRNA in HBV-HCC carcinogenesis: Why no therapeutic agents after 30 years?

K Sartorius, B Sartorius, C Winkler, A Chuturgoon… - …, 2024 - search.ebscohost.com
Hepatitis B-associated hepatocellular carcinoma (HBV-HCC) remains an intractable high-
mortality solid tumor cancer that accounted for 42% of global HCC cases in 2019. Despite …